Mandatory Complete Removal of Cardiac Implantable Electronic Devices in Staphylococcus aureus Bacteremia

Epidemiology and Risk Assessment

• In patients with Staphylococcus aureus bacteremia, the prevalence of an underlying cardiac implantable electronic device (CIED) infection is approximately 30–40 %【1】.

Guideline Recommendation

• The American Heart Association issues a Class I recommendation that the entire CIED system—including all leads—must be removed when blood cultures grow Staphylococcus aureus, even in the absence of overt device infection【2】【3】.

Clinical Factors Strengthening the Indication for Removal

• Recent device implantation (within 3 months) markedly increases the likelihood that bacteremia originates from the CIED and therefore mandates extraction【2】.

Pre‑Removal Diagnostic Work‑up

• Transesophageal echocardiography (TEE) is required before extraction to detect lead vegetations or valvular involvement, which influences both the duration of antimicrobial therapy and the timing of re‑implantation【2】【1】.

Antimicrobial Therapy Duration After Device Extraction

• Uncomplicated bloodstream infection: minimum 14 days of targeted antibiotics after complete device removal【2】【3】.
• Lead vegetations without valve involvement: therapy for 14 days counted from the first negative blood culture【2】.
• Complicated infection (e.g., endocarditis, persistent bacteremia after removal, septic thrombophlebitis, osteomyelitis, or metastatic abscesses): 4–6 weeks of treatment【2】【3】.

Timing and Strategy for Device Re‑implantation

• Re‑implantation must be delayed until blood cultures have been negative for at least 72 hours【2】.
• If only lead vegetations are present (no valve involvement), re‑implant after the 72‑hour negative‑culture period【2】.
• If valve vegetations are present, postpone re‑implantation for ≥14 days from the first negative blood culture【2】.

Reassessment of Device Necessity and Placement Technique

• Approximately one‑third to one‑half of patients may no longer require a CIED after infection resolution, and this should be reassessed before re‑implantation【3】.
• When re‑implantation is indicated, the device should be placed on the contralateral side to reduce reinfection risk【3】.
• If contralateral placement is not feasible, alternative sites such as the iliac vein or epicardial location may be considered【3】.

Common Pitfalls to Avoid

• Do not postpone device removal while awaiting TEE or completing prolonged antibiotic courses; early extraction is essential【1】.
• Do not assume the device is uninvolved merely because the pocket appears normal—Staphylococcus aureus bacteremia with a CIED is treated as device infection until proven otherwise【2】【1】.
• Do not perform ipsilateral re‑implantation, as this significantly raises the risk of reinfection【3】.
• Do not re‑implant before confirming ≥72 hours of negative blood cultures, which is the minimum clearance period【2】.

Management After ICD Removal for Bacteremia-Related Infection

Immediate Post-Removal Management

• The American Heart Association recommends drawing repeat blood cultures immediately after device extraction to document clearance of bacteremia 4, 5
• Blood cultures must remain negative for at least 72 hours before considering new device placement, according to the American College of Cardiology 4, 6
• If valve vegetations were present on transesophageal echocardiography (TEE), the American Heart Association recommends delaying reimplantation for at least 14 days from the first negative blood culture 7, 8

Antibiotic Therapy Duration

• The Infectious Diseases Society of America recommends a minimum of 14 days of parenteral therapy after device removal for bloodstream infection without complications 4, 9, 10
• For sustained bacteremia (≥24 hours) despite removal, the American Heart Association recommends 4 weeks of parenteral therapy, even if TEE is negative 5, 11
• For complicated infection (endocarditis, septic thrombophlebitis, osteomyelitis, or metastatic foci), the Infectious Diseases Society of America recommends 4-6 weeks of antimicrobial therapy 4, 9, 10

Device Reimplantation Strategy

• The American College of Cardiology recommends determining if the patient still requires a device before reimplantation, as one-third to one-half of patients may not need reimplantation 10, 6
• The American Heart Association recommends reimplanting on the contralateral side or alternative site to minimize reinfection risk 10, 8

Critical Monitoring Points

• The American Heart Association recommends watching for persistent infection, as bacteremia persisting ≥24 hours despite appropriate antibiotics and device removal indicates complicated infection requiring extended therapy 5, 11
• The Infectious Diseases Society of America recommends evaluating for metastatic septic complications (osteomyelitis, organ abscess, septic emboli) which would extend antibiotic duration to 4+ weeks 4, 9, 6